美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=OPANA ER"
符合检索条件的记录共14
2 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称OPANA ER
申请号021610产品号001
活性成分OXYMORPHONE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2006/06/22申请机构ENDO PHARMACEUTICALS INC
2药品名称OPANA ER
申请号021610产品号002
活性成分OXYMORPHONE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2006/06/22申请机构ENDO PHARMACEUTICALS INC
3药品名称OPANA ER
申请号021610产品号003
活性成分OXYMORPHONE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2006/06/22申请机构ENDO PHARMACEUTICALS INC
4药品名称OPANA ER
申请号021610产品号004
活性成分OXYMORPHONE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格40MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2006/06/22申请机构ENDO PHARMACEUTICALS INC
5药品名称OPANA ER
申请号021610产品号005
活性成分OXYMORPHONE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2008/02/29申请机构ENDO PHARMACEUTICALS INC
6药品名称OPANA ER
申请号021610产品号006
活性成分OXYMORPHONE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格15MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2008/02/29申请机构ENDO PHARMACEUTICALS INC
7药品名称OPANA ER
申请号021610产品号007
活性成分OXYMORPHONE HYDROCHLORIDE市场状态停止上市
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格30MG
治疗等效代码参比药物
批准日期2008/02/29申请机构ENDO PHARMACEUTICALS INC
8药品名称OPANA ER
申请号201655产品号001
活性成分OXYMORPHONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格5MG
治疗等效代码参比药物
批准日期2011/12/09申请机构ENDO PHARMACEUTICALS INC
9药品名称OPANA ER
申请号201655产品号002
活性成分OXYMORPHONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格7.5MG
治疗等效代码参比药物
批准日期2011/12/09申请机构ENDO PHARMACEUTICALS INC
10药品名称OPANA ER
申请号201655产品号003
活性成分OXYMORPHONE HYDROCHLORIDE市场状态处方药
剂型或给药途径TABLET, EXTENDED RELEASE;ORAL规格10MG
治疗等效代码参比药物
批准日期2011/12/09申请机构ENDO PHARMACEUTICALS INC